Synthesis 2012; 44(20): 3216-3224
DOI: 10.1055/s-0032-1317145
paper
© Georg Thieme Verlag Stuttgart · New York

Palladium-Catalyzed Synthesis of Substituted Pyrido[2,3-d]pyridazines at Positions 5 and 8

Authors

  • Mohamed A. Ibrahim

    a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
    c   Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig-44519, Egypt
    d   Department of Organic Chemistry, Misr University for Science and Technology, Al-Motamayez District, P.O. Box 77, 6th of October City, Egypt
  • Emilie Blaise

    a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
  • Olivier Lozach

    b   Station Biologique de Roscoff, CNRS – USR3151, Place G. Teissier, 29680 Roscoff, France
  • Claude Szalata

    a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
  • Martine Schmitt

    a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
  • Abd-Allah. S. El-Etrawy

    d   Department of Organic Chemistry, Misr University for Science and Technology, Al-Motamayez District, P.O. Box 77, 6th of October City, Egypt
  • Mohamed Elagawany

    a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
    d   Department of Organic Chemistry, Misr University for Science and Technology, Al-Motamayez District, P.O. Box 77, 6th of October City, Egypt
  • Said A. El-Feky

    c   Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig-44519, Egypt
  • Zakaria K. Abdel-Samii

    c   Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig-44519, Egypt
  • Laurent Meijer

    b   Station Biologique de Roscoff, CNRS – USR3151, Place G. Teissier, 29680 Roscoff, France
  • Jean-Jacques Bourguignon

    a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
  • Frédéric Bihel*

    a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
Further Information

Publication History

Received: 22 June 2012

Accepted after revision: 27 July 2012

Publication Date:
31 August 2012 (online)


Graphical Abstract

Preview

Abstract

Several synthetic strategies were developed for the preparation of highly substituted pyrido[2,3-d]pyridazines. We particularly focused on the impact of the pyridine nitrogen atom on pyridazine ring reactivity toward aromatic substitutions, alkylations, or pallado-catalyzed cross-coupling reactions.

Supporting Information